AVH News: AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System - 4th Nov 2022, 11:15am

annb0t

Top 20
AVITA Medical

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today that the Food and Drug Administration (FDA) granted the RECELL System designations as a Breakthrough Device for its proposed soft tissue repair indication as well as its vitiligo indicat...

>>> Read more: AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
 
Top Bottom